Core Laboratories N.V. (CLB) Earnings History
Profitable31 years of earnings data (1995–2025) · Positive TTM net income
Loading earnings history...
Core Laboratories N.V. (CLB) Earnings Overview
As of June 16, 2026, Core Laboratories N.V. (CLB) reported trailing twelve-month net income of $31M, reflecting +3.0% year-over-year growth. The company earned $0.68 per diluted share over the past four quarters, with a net profit margin of 6.0%.
Looking at the long-term picture, CLB's historical earnings data spans multiple years. The company achieved its highest annual net income of $257M in fiscal 2014.
Core Laboratories N.V. maintains positive profitability with a gross margin of 17.9%, operating margin of 9.3%, and net margin of 6.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including LBRT ($150M net income, 3.7% margin), NINE ($62M net income, -9.1% margin), PUMP (-$12M net income, 0.1% margin), CLB has outperformed on profitability metrics. Compare CLB vs LBRT →
CLB Earnings vs Peers
Earnings metrics vs comparable public companies
CLB Historical Earnings Data (1995–2025)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $32M | +1.3% | $49M | $0.68 | 6.0% | 9.3% |
| 2024 | $31M | -14.4% | $59M | $0.66 | 6.0% | 11.2% |
| 2023 | $37M | +88.5% | $55M | $0.77 | 7.2% | 10.7% |
| 2022 | $19M | -1.4% | $42M | $0.42 | 4.0% | 8.5% |
| 2021 | $20M | +120.2% | $45M | $0.42 | 4.2% | 9.6% |
| 2020 | -$98M | -195.7% | -$77M | $-2.16 | -20.0% | -15.8% |
| 2019 | $102M | +28.2% | $97M | $2.10 | 15.3% | 14.5% |
| 2018 | $80M | -4.3% | $119M | $1.79 | 11.3% | 16.9% |
| 2017 | $83M | +30.1% | $112M | $1.88 | 12.6% | 17.0% |
| 2016 | $64M | -44.4% | $86M | $1.45 | 10.7% | 14.5% |
| 2015 | $115M | -55.4% | $161M | $2.68 | 14.4% | 20.2% |
| 2014 | $257M | +6.0% | $347M | $5.77 | 23.7% | 31.9% |
| 2013 | $243M | +12.4% | $333M | $5.28 | 22.6% | 31.1% |
| 2012 | $216M | +17.0% | $297M | $4.54 | 22.0% | 30.3% |
| 2011 | $185M | +27.4% | $251M | $3.82 | 20.3% | 27.6% |
| 2010 | $145M | +27.6% | $227M | $3.00 | 18.2% | 28.6% |
| 2009 | $114M | -20.9% | $187M | $2.43 | 16.3% | 26.9% |
| 2008 | $144M | +18.6% | $207M | $2.74 | 18.4% | 26.5% |
| 2007 | $121M | +46.5% | $184M | $2.48 | 18.1% | 27.4% |
| 2006 | $83M | +164.8% | $124M | $1.54 | 14.4% | 21.5% |
| 2005 | $31M | +154.0% | $61M | $0.56 | 6.5% | 12.6% |
| 2004 | $12M | -34.3% | $47M | $0.22 | 2.9% | 10.9% |
| 2003 | $19M | +306.4% | $33M | $0.30 | 4.6% | 8.2% |
| 2002 | -$9M | -143.9% | $21M | $-0.14 | -2.5% | 5.7% |
| 2001 | $21M | +7.7% | $37M | $0.30 | 5.5% | 9.7% |
| 2000 | $19M | +463.3% | $35M | $0.27 | 5.7% | 10.3% |
| 1999 | $3M | -83.0% | $27M | $0.04 | 1.1% | 9.0% |
| 1998 | $20M | +29.9% | $41M | $0.29 | 7.0% | 14.3% |
| 1997 | $15M | +100.0% | $27M | $0.30 | 7.2% | 12.8% |
| 1996 | $8M | +83.3% | $13M | $0.17 | 7.3% | 11.9% |
| 1995 | $4M | - | $10M | $0.11 | 5.2% | 12.6% |
Download Data
Export CLB earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in CLB back in 1995?
Total return with dividends reinvested · 31+ years of data
Calculate ReturnsHow much would $100/month in CLB be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs CLB Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCLB vs XOM — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Exxon Mobil Corporation.
Compare NowCLB — Frequently Asked Questions
Quick answers to the most common questions about buying CLB stock.
What is CLB earnings per share (EPS)?
CLB trailing twelve-month (TTM) diluted EPS is $0.68, reflecting +3.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1995 to 2025 is available in the table on this page.
What is Core Laboratories N.V.'s net income?
Core Laboratories N.V. (CLB) trailing twelve-month net income is $31M as of 2025. Earnings grew +3.0% year-over-year. Core Laboratories N.V. has been profitable for 5 consecutive years.
Is CLB profitable?
Yes, CLB is profitable with a TTM net income of $31M and a net profit margin of +6.0%. Core Laboratories N.V. has generated profits for 5 consecutive years.
What is CLB's earnings growth rate?
CLB compound annual EPS growth rates (CAGR): 1-Year: +3.0%, 3-Year: +17.4%, 5-Year: N/A, 10-Year: -12.8%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1995 to 2025.
What are CLB's profit margins?
Core Laboratories N.V. net profit margin is +6.0%, operating margin is +9.3%, and gross margin is +17.9%. Margins are within a typical range for the sector. Return on Equity is +11.8%.
Is CLB growing earnings?
CLB earnings growth is slowing. Current YoY EPS growth of +3.0% trails the 5-year CAGR of N/A. TTM net income is $31M.
What was CLB's best earnings year?
Core Laboratories N.V.'s highest annual net income on record is $257M, achieved in fiscal year 2014. Earnings history on this page spans 1995 to 2025 and includes all annual and quarterly figures.
What were CLB's earnings last quarter?
CLB's most recent reported quarter was Q1 2026. Net income was $-789000.00 with diluted EPS of $-0.02. For a full breakdown of all quarters, see the quarterly earnings table on this page.